These data suggest that TLR4 was the upstream molecule of IL6 that promoted tumour development, and it has been reported that TLR4 and NF‐κB signalling are required to control the regulation of the IL‐6 mRNA stabilizing molecule Arid5a.34 The gene discussed is ARID5A; the disease is neoplasm.